| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 9.9% | $154,945 | 3,873,632 | Ayrton Capital LLC | 31 Dec 2024 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA). This represents 0% of the company’s total 39,127,596 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$5,692 | $0.01 | 0 |
| 2025 Q2 | 803,455 | $5,693 | -$228,178 | $0.01 | 4 |
| 2025 Q1 | 4,630,694 | $247,055 | -$42,442 | $0.05 | 21 |
| 2024 Q4 | 3,677,666 | $2,006,120 | +$43,551 | $0.55 | 19 |
| 2024 Q3 | 3,582,574 | $3,462,151 | -$391,653 | $0.98 | 20 |
| 2024 Q2 | 3,957,054 | $4,771,342 | -$1,814,246 | $1.22 | 32 |
| 2024 Q1 | 4,525,864 | $17,135,805 | +$1,823,668 | $3.78 | 42 |
| 2023 Q4 | 4,581,171 | $3,023,621 | -$1,830,452 | $0.66 | 34 |
| 2023 Q3 | 6,201,312 | $24,189,517 | -$2,278,623 | $3.90 | 38 |
| 2023 Q2 | 6,758,932 | $40,609,281 | -$2,357,689 | $6.01 | 36 |
| 2023 Q1 | 7,149,803 | $47,483,735 | +$37,328,905 | $6.64 | 16 |